Article
Arrhythmia pharmacogenomics: methodological considerations.
Current pharmaceutical design - 1 Jan 2009
Roden Dan M, Kannankeri Prince J, Darbar Dawood
Abstract excerpt
Abnormalities of cardiac rhythm are common clinical problems, resulting in symptoms such as palpitations, breathlessness, stroke, and sudden death. Drugs used to treat arrhythmias have variable actions ranging from completely effective to serious adverse effects, including (paradoxically) sudden death due to drug-induced arrhythmias. Experiments to define the genetic basis for arrhythmia susceptibility and...
Topics
- Animals
- Anti-Arrhythmia Agents
- Arrhythmias, Cardiac
- Death, Sudden, Cardiac
- Humans
- Pharmacogenetics
- Phenotype
